Organon Beheer
Beheer criteriumcontroles 3/4
De CEO Organon is Kevin Ali, benoemd in Jun2021, heeft een ambtstermijn van 3.42 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 14.83M, bestaande uit 8.4% salaris en 91.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.056% van de aandelen van het bedrijf, ter waarde $ 2.13M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.4 jaar en 3.4 jaar.
Belangrijke informatie
Kevin Ali
Algemeen directeur
US$14.8m
Totale compensatie
| Percentage CEO-salaris | 8.4% |
| Dienstverband CEO | 3.4yrs |
| Eigendom CEO | 0.06% |
| Management gemiddelde ambtstermijn | 3.4yrs |
| Gemiddelde ambtstermijn bestuur | 3.4yrs |
Recente managementupdates
Recent updates
Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)
Nov 13The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Nov 04
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Sep 19These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way
Sep 13Organon & Co.: Cheap With Caveats
Aug 22Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
Aug 09Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price
Aug 07Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
Jul 30Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year
May 29Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals
May 10Four Reasons Why Organon Stock Is A Good Buy
May 07Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings
Apr 21Organon Stock Is Still Worth A Look
Feb 24Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Feb 19Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
Feb 16Organon: What I'm Looking For In This 8% Yield In 2024
Jan 03High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
Dec 19Organon: It's Darkest Before The Dawn
Nov 30Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace
Nov 07Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28
Nov 05Organon: The Federal Reserve Black Swan (Rating Upgrade)
Oct 046% Yield And Significantly Undervalued: A Closer Look At Organon
Sep 10Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk
Aug 10Organon & Co.: A Tough Spot To Be In Right Now
Jul 16Organon goes ex-dividend tomorrow
Feb 23Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 19Is There Anything Organic Or Interesting About Organon?
Feb 07Organon goes ex-dividend tomorrow
Nov 09Organon's (NYSE:OGN) Dividend Will Be $0.28
Nov 08Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)
Nov 05Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | n/a | n/a | US$1b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$15m | US$1m | US$1b |
| Sep 30 2023 | n/a | n/a | US$585m |
| Jun 30 2023 | n/a | n/a | US$754m |
| Mar 31 2023 | n/a | n/a | US$746m |
| Dec 31 2022 | US$14m | US$1m | US$917m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$1b |
| Dec 31 2021 | US$19m | US$1m | US$1b |
Compensatie versus markt: De totale vergoeding ($USD 14.83M ) Kevin } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.60M ).
Compensatie versus inkomsten: De vergoeding van Kevin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Kevin Ali (64 yo)
3.4yrs
Tenure
US$14,832,272
Compensatie
Mr. Kevin Ali is Chief Executive Officer and Director of Organon & Co. since June 2, 2021. Mr. Ali served as the President of Global Enterprise Portfolio Strategy at Merck & Co., Inc. from 2019 to 2021 and...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$14.83m | 0.056% $ 2.1m | |
| Executive VP & CFO | 3.4yrs | US$5.21m | 0.036% $ 1.4m | |
| Executive VP | 1.8yrs | US$3.19m | 0.011% $ 429.4k | |
| Executive VP & Chief Commercial Officer | 3.8yrs | US$3.84m | 0.021% $ 782.2k | |
| Executive VP and Head of Manufacturing & Supply | 3.4yrs | US$3.74m | 0.017% $ 631.6k | |
| Executive VP & Chief Information Officer | 3.4yrs | geen gegevens | 0.019% $ 739.4k | |
| Head of Investor Relations | 3.8yrs | geen gegevens | geen gegevens | |
| Chief Ethics & Compliance Officer | no data | geen gegevens | geen gegevens | |
| Chief Communications Officer | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Corporate Development | no data | geen gegevens | 0.0075% $ 285.3k | |
| Executive VP & Chief Human Resources Officer | 3.4yrs | geen gegevens | 0.013% $ 481.0k | |
| Executive VP & Head of Global Business Services | 3.4yrs | geen gegevens | 0.0096% $ 364.6k |
3.4yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van OGN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$14.83m | 0.056% $ 2.1m | |
| Independent Chairman of the Board | 3.4yrs | US$450.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$335.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$320.00k | 0.00025% $ 9.5k | |
| Independent Director | 3.4yrs | US$320.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$330.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$320.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$345.00k | 0% $ 0 | |
| Independent Director | 3.4yrs | US$320.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$330.00k | geen gegevens | |
| Independent Director | 3.4yrs | US$320.00k | 0% $ 0 | |
| Independent Director | 3.4yrs | US$330.00k | 0% $ 0 |
3.4yrs
Gemiddelde duur
64yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van OGN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).